Brendan Hannah

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Brendan Hannah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brendan Hannah:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. CBO, COO & CCO Common Shares 361,827 $340,117 $0.9400 05 Dec 2025 Direct
Quince Therapeutics, Inc. CBO, COO & CCO Warrants 37,736 $4,717 $0.1250 18 Jun 2025 Direct
Quince Therapeutics, Inc. CBO, COO & CCO Employee Stock Option (Right to Buy) 199,720 05 Dec 2025 Direct

Insider Reports Filed by Brendan Hannah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QNCX Quince Therapeutics, Inc. 05 Dec 2025 4 +$25,012 4 CBO, COO & CCO 08 Dec 2025, 08:12
QNCX Quince Therapeutics, Inc. 18 Jun 2025 2 +$50,000 4 CBO, COO & CCO 23 Jun 2025, 08:48
QNCX Quince Therapeutics, Inc. 28 Jan 2025 1 $0 4 CBO, COO and CCO 11 Feb 2025, 17:41
QNCX Quince Therapeutics, Inc. 19 Aug 2024 6 +$24,166 4 CHIEF BUSINESS OFFICER AND COO 21 Aug 2024, 18:38
QNCX Quince Therapeutics, Inc. 04 Jun 2024 2 +$30,834 4 CHIEF BUSINESS OFFICER AND COO 05 Jun 2024, 14:37
QNCX Quince Therapeutics, Inc. 01 Feb 2024 1 $0 4 CHIEF BUSINESS OFFICER AND COO 02 Feb 2024, 17:53
QNCX Quince Therapeutics, Inc. 24 Oct 2023 1 $0 4 Chief Business Officer and COO 26 Oct 2023, 17:54
QNCX Quince Therapeutics, Inc. 08 Aug 2023 1 +$87,550 4 Chief Business Officer 09 Aug 2023, 18:21
QNCX Quince Therapeutics, Inc. 01 Feb 2023 1 $0 4 Chief Business Officer 02 Feb 2023, 17:29
QNCX Cortexyme, Inc. 19 May 2022 1 $0 4/A Chief Business Officer 27 May 2022, 17:34
QNCX Cortexyme, Inc. 19 May 2022 0 $0 3 Chief Business Officer 23 May 2022, 20:02